AbbVie Boosts 2021 Earnings Forecast
October 29 2021 - 8:29AM
Dow Jones News
By Michael Dabaie
AbbVie Inc. boosted its earnings guidance for 2021, citing its
momentum.
The biopharmaceutical company raised its full-year GAAP earnings
per share guidance range to $6.29 to $6.33, from $6.04 to $6.14.
For adjusted earnings per share, the company boosted its outlook to
$12.63 to $12.67, from $12.52 to $12.62.
"Based upon our strong momentum, we are increasing our full-year
2021 EPS guidance," said Chief Executive Richard A. Gonzalez.
Shares rose 2.6% premarket to $112.57.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
October 29, 2021 08:14 ET (12:14 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2023 to Apr 2024
